Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1473128

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1473128

Europe Testosterone Replacement Therapy Market Size, Share & Trends Analysis Report By End User (Clinics, and Hospital), By Product Type (Injectables, Topical, and Others), By Active, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Testosterone Replacement Therapy Market would witness market growth of 3.7% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Testosterone Replacement Therapy Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $163.9 million by 2031. The UK market is exhibiting a CAGR of 3.2% during (2024 - 2031). Additionally, The France market would experience a CAGR of 4.5% during (2024 - 2031).

Andropause, often referred to as male menopause, is a natural age-related decline in testosterone levels that occurs in aging men. While not all men experience significant symptoms, some may develop symptoms similar to those seen in hypogonadism, such as fatigue, reduced libido, mood changes, and decreased muscle mass. TRT can help manage these symptoms and improve the overall quality of life in aging men experiencing andropause.

In addition, testosterone plays a crucial role in erectile function by stimulating nitric oxide production, which relaxes blood vessels in the penis, allowing for increased blood flow and erection. Low testosterone levels can contribute to erectile dysfunction (ED), and TRT may be prescribed as part of a comprehensive treatment plan for men with ED associated with hypogonadism.

As obesity rates rise in the UK, there may be a corresponding increase in the prevalence of hypogonadism or testosterone deficiency among obese individuals. This higher prevalence of hypogonadism could drive greater demand for TRT to address hormone imbalances and associated symptoms. Therefore, the market is growing as a result of the high rates of obesity and the growth of the pharmaceutical business.

Based on End User, the market is segmented into Clinics, and Hospital. Based on Product Type, the market is segmented into Injectables, Topical, and Others. Based on Active ingredients, the market is segmented into Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate, Testosterone, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Endo International PLC
  • AbbVie, Inc.
  • Pfizer, Inc.
  • Eli Lilly And Company
  • Teva Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Ferring Holdings SA
  • Marius Pharmaceuticals LLC
  • Besins Healthcare Monaco S.A.M.
  • Acrux Limited

Europe Testosterone Replacement Therapy Market Report Segmentation

By End User

  • Clinics
  • Hospital

By Product Type

  • Injectables
  • Topical
  • Others

By Active ingredient

  • Testosterone Cypionate
  • Testosterone Undecanoate
  • Testosterone Enanthate
  • Testosterone
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Europe Testosterone Replacement Therapy Market, by End User
    • 1.4.2Europe Testosterone Replacement Therapy Market, by Product Type
    • 1.4.3Europe Testosterone Replacement Therapy Market, by Active ingredient
    • 1.4.4Europe Testosterone Replacement Therapy Market, by Country
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Restraints
    • 3.2.3Market Opportunities
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Europe Testosterone Replacement Therapy Market by End User

  • 4.1Europe Clinics Market by Country
  • 4.2Europe Hospital Market by Country

Chapter 5.Europe Testosterone Replacement Therapy Market by Product Type

  • 5.1Europe Injectables Market by Country
  • 5.2Europe Topical Market by Country
  • 5.3Europe Others Market by Country

Chapter 6.Europe Testosterone Replacement Therapy Market by Active ingredients

  • 6.1Europe Testosterone Cypionate Market by Country
  • 6.2Europe Testosterone Undecanoate Market by Country
  • 6.3Europe Testosterone Enanthate Market by Country
  • 6.4Europe Testosterone Market by Country
  • 6.5Europe Others Market by Country

Chapter 7.Europe Testosterone Replacement Therapy Market by Country

  • 7.1Germany Testosterone Replacement Therapy Market
    • 7.1.1Germany Testosterone Replacement Therapy Market by End User
    • 7.1.2Germany Testosterone Replacement Therapy Market by Product Type
    • 7.1.3Germany Testosterone Replacement Therapy Market by Active ingredients
  • 7.2UK Testosterone Replacement Therapy Market
    • 7.2.1UK Testosterone Replacement Therapy Market by End User
    • 7.2.2UK Testosterone Replacement Therapy Market by Product Type
    • 7.2.3UK Testosterone Replacement Therapy Market by Active ingredients
  • 7.3France Testosterone Replacement Therapy Market
    • 7.3.1France Testosterone Replacement Therapy Market by End User
    • 7.3.2France Testosterone Replacement Therapy Market by Product Type
    • 7.3.3France Testosterone Replacement Therapy Market by Active ingredients
  • 7.4Russia Testosterone Replacement Therapy Market
    • 7.4.1Russia Testosterone Replacement Therapy Market by End User
    • 7.4.2Russia Testosterone Replacement Therapy Market by Product Type
    • 7.4.3Russia Testosterone Replacement Therapy Market by Active ingredients
  • 7.5Spain Testosterone Replacement Therapy Market
    • 7.5.1Spain Testosterone Replacement Therapy Market by End User
    • 7.5.2Spain Testosterone Replacement Therapy Market by Product Type
    • 7.5.3Spain Testosterone Replacement Therapy Market by Active ingredients
  • 7.6Italy Testosterone Replacement Therapy Market
    • 7.6.1Italy Testosterone Replacement Therapy Market by End User
    • 7.6.2Italy Testosterone Replacement Therapy Market by Product Type
    • 7.6.3Italy Testosterone Replacement Therapy Market by Active ingredients
  • 7.7Rest of Europe Testosterone Replacement Therapy Market
    • 7.7.1Rest of Europe Testosterone Replacement Therapy Market by End User
    • 7.7.2Rest of Europe Testosterone Replacement Therapy Market by Product Type
    • 7.7.3Rest of Europe Testosterone Replacement Therapy Market by Active ingredients

Chapter 8.Company Profiles

  • 8.1Endo International PLC
    • 8.1.1Company Overview
    • 8.1.2Financial Analysis
    • 8.1.3Segmental Analysis
    • 8.1.4Research & Development Expense
    • 8.1.5SWOT Analysis
  • 8.2AbbVie, Inc.
    • 8.2.1Company Overview
    • 8.2.2Financial Analysis
    • 8.2.3Regional Analysis
    • 8.2.4Research & Development Expense
    • 8.2.5SWOT Analysis
  • 8.3Pfizer, Inc.
    • 8.3.1Company Overview
    • 8.3.2Financial Analysis
    • 8.3.3Regional & Segmental Analysis
    • 8.3.4Research & Development Expense
    • 8.3.5Recent strategies and developments:
      • 8.3.5.1Acquisition and Mergers:
    • 8.3.6SWOT Analysis
  • 8.4Eli Lilly And Company
    • 8.4.1Company Overview
    • 8.4.2Financial Analysis
    • 8.4.3Regional Analysis
    • 8.4.4Research & Development Expenses
    • 8.4.5Recent strategies and developments:
      • 8.4.5.1Partnerships, Collaborations, and Agreements:
    • 8.4.6SWOT Analysis
  • 8.5Teva Pharmaceutical Industries Ltd.
    • 8.5.1Company Overview
    • 8.5.2Financial Analysis
    • 8.5.3Regional Analysis
    • 8.5.4Research & Development Expenses
    • 8.5.5SWOT Analysis
  • 8.6Amneal Pharmaceuticals, Inc.
    • 8.6.1Company Overview
    • 8.6.2Financial Analysis
    • 8.6.3Segmental Analysis
    • 8.6.4Research & Development Expenses
    • 8.6.5SWOT Analysis
  • 8.7Ferring Holdings SA
    • 8.7.1Company Overview
    • 8.7.2Financial Analysis
    • 8.7.3Regional Analysis
    • 8.7.4Research and Development Expense
    • 8.7.5SWOT Analysis
  • 8.8Marius Pharmaceuticals LLC
    • 8.8.1Company Overview
    • 8.8.2Recent strategies and developments:
      • 8.8.2.1Trials & Approvals:
  • 8.9Besins Healthcare Monaco S.A.M.
    • 8.9.1Company Overview
    • 8.9.2Recent strategies and developments:
      • 8.9.2.1Geographical Expansions:
  • 8.10.Acrux Limited
    • 8.10.1Company Overview
    • 8.10.2Financial Analysis
    • 8.10.3Regional Analysis
    • 8.10.4Research & Development Expenses
    • 8.10.5SWOT Analysis

LIST OF TABLES

  • TABLE 1Europe Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
  • TABLE 2Europe Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
  • TABLE 3Europe Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
  • TABLE 4Europe Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
  • TABLE 5Europe Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 6Europe Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 7Europe Hospital Market by Country, 2020 - 2023, USD Million
  • TABLE 8Europe Hospital Market by Country, 2024 - 2031, USD Million
  • TABLE 9Europe Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
  • TABLE 10Europe Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
  • TABLE 11Europe Injectables Market by Country, 2020 - 2023, USD Million
  • TABLE 12Europe Injectables Market by Country, 2024 - 2031, USD Million
  • TABLE 13Europe Topical Market by Country, 2020 - 2023, USD Million
  • TABLE 14Europe Topical Market by Country, 2024 - 2031, USD Million
  • TABLE 15Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 16Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 17Europe Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
  • TABLE 18Europe Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
  • TABLE 19Europe Testosterone Cypionate Market by Country, 2020 - 2023, USD Million
  • TABLE 20Europe Testosterone Cypionate Market by Country, 2024 - 2031, USD Million
  • TABLE 21Europe Testosterone Undecanoate Market by Country, 2020 - 2023, USD Million
  • TABLE 22Europe Testosterone Undecanoate Market by Country, 2024 - 2031, USD Million
  • TABLE 23Europe Testosterone Enanthate Market by Country, 2020 - 2023, USD Million
  • TABLE 24Europe Testosterone Enanthate Market by Country, 2024 - 2031, USD Million
  • TABLE 25Europe Testosterone Market by Country, 2020 - 2023, USD Million
  • TABLE 26Europe Testosterone Market by Country, 2024 - 2031, USD Million
  • TABLE 27Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 28Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 29Europe Testosterone Replacement Therapy Market by Country, 2020 - 2023, USD Million
  • TABLE 30Europe Testosterone Replacement Therapy Market by Country, 2024 - 2031, USD Million
  • TABLE 31Germany Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
  • TABLE 32Germany Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
  • TABLE 33Germany Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
  • TABLE 34Germany Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
  • TABLE 35Germany Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
  • TABLE 36Germany Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
  • TABLE 37Germany Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
  • TABLE 38Germany Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
  • TABLE 39UK Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
  • TABLE 40UK Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
  • TABLE 41UK Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
  • TABLE 42UK Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
  • TABLE 43UK Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
  • TABLE 44UK Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
  • TABLE 45UK Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
  • TABLE 46UK Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
  • TABLE 47France Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
  • TABLE 48France Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
  • TABLE 49France Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
  • TABLE 50France Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
  • TABLE 51France Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
  • TABLE 52France Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
  • TABLE 53France Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
  • TABLE 54France Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
  • TABLE 55Russia Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
  • TABLE 56Russia Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
  • TABLE 57Russia Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
  • TABLE 58Russia Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
  • TABLE 59Russia Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
  • TABLE 60Russia Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
  • TABLE 61Russia Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
  • TABLE 62Russia Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
  • TABLE 63Spain Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
  • TABLE 64Spain Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
  • TABLE 65Spain Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
  • TABLE 66Spain Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
  • TABLE 67Spain Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
  • TABLE 68Spain Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
  • TABLE 69Spain Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
  • TABLE 70Spain Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
  • TABLE 71Italy Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
  • TABLE 72Italy Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
  • TABLE 73Italy Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
  • TABLE 74Italy Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
  • TABLE 75Italy Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
  • TABLE 76Italy Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
  • TABLE 77Italy Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
  • TABLE 78Italy Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
  • TABLE 79Rest of Europe Testosterone Replacement Therapy Market, 2020 - 2023, USD Million
  • TABLE 80Rest of Europe Testosterone Replacement Therapy Market, 2024 - 2031, USD Million
  • TABLE 81Rest of Europe Testosterone Replacement Therapy Market by End User, 2020 - 2023, USD Million
  • TABLE 82Rest of Europe Testosterone Replacement Therapy Market by End User, 2024 - 2031, USD Million
  • TABLE 83Rest of Europe Testosterone Replacement Therapy Market by Product Type, 2020 - 2023, USD Million
  • TABLE 84Rest of Europe Testosterone Replacement Therapy Market by Product Type, 2024 - 2031, USD Million
  • TABLE 85Rest of Europe Testosterone Replacement Therapy Market by Active ingredients, 2020 - 2023, USD Million
  • TABLE 86Rest of Europe Testosterone Replacement Therapy Market by Active ingredients, 2024 - 2031, USD Million
  • TABLE 87Key Information - Endo International PLC
  • TABLE 88Key information - AbbVie, Inc.
  • TABLE 89Key Information - Pfizer, Inc.
  • TABLE 90Key Information - Eli Lilly And Company
  • TABLE 91Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 92Key Information - Amneal Pharmaceuticals, INc.
  • TABLE 93key information - Ferring Holdings SA
  • TABLE 94Key Information - Marius Pharmaceuticals LLC
  • TABLE 95Key Information - Besins Healthcare Monaco S.A.M.
  • TABLE 96Key Information - Acrux Limited
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!